SCHEMBL5518581

SCHEMBL5518581

O=CCc1ccc(OCCCO)c(CCl)c1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.39
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.36
MAPK1 P28482 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
TUBB1 Q9H4B7 1/20 0.35
CNR2 P34972 2/20 0.35
PPARA Q07869 2/20 0.35
CNR1 P21554 1/20 0.35
ALDH1A1 P00352 2/20 0.33
MAPT P10636 3/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
POLB P06746 1/20 0.33
THRB P10828 2/20 0.32
STAT3 P40763 1/20 0.32
GAA P10253 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5509230 0.84 MAPT (0.46) KDM4ELMNATP53L3MBTL1CNR2
SCHEMBL5504133 0.80 ALDH1A1 (0.43) KDM4ELMNAMAPK1L3MBTL1ALDH1A1
SCHEMBL5116144 0.77 SMN1; SMN2 (0.49) MAPK1L3MBTL1ALDH1A1SMN1; SMN2POLB
SCHEMBL1557719 0.76 ALDH1A1 (0.46) CNR2PPARAALDH1A1
SCHEMBL1545756 0.74 S1PR2 (0.41) TUBB1CNR2PPARACNR1GAA
SCHEMBL11288589 0.71
SCHEMBL15019690 0.71 ALDH1A1 (0.46) KDM4ELMNAMAPK1L3MBTL1ALDH1A1
SCHEMBL11202537 0.71 XDH (0.41) KDM4ELMNACNR2CNR1ALDH1A1
SCHEMBL1766003 0.70 PPARA (0.54) KDM4ELMNAL3MBTL1PPARAALDH1A1
SCHEMBL8710163 0.68 MAPT (0.41) KDM4ETP53MAPK1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1784182-A1 2-SULFANYL-BENZIMIDAZOL-1-YL-ACETIC ACID DERIVATIVES AS CRTH2 ANTAGONISTS Actelion Pharmaceuticals Ltd. (CH) 2007-05-16 EP disclosed
WO-2006021418-A1 2-SULFANYL-BENZOIMIDAZOL-1-YL-ACETIC ACID DERIVATIVES AS CRTH2 ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2006-03-02 WO disclosed